Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-19

Clinical Trial Update: Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the addition of interferon alfa to chemotherapy, with or without bone marrow or peripheral stem cell transplantation, for treating myel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon Alfa (interferon alfa)

Snippet

Sponsor: Medical Research Council | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Status: UNKNOWN